Back to top
more

Janus Henderson Global Life Sciences Fund - D Shares: (MF: JNGLX)

(NASDAQ Mutual Funds) As of Apr 23, 2025 08:00 PM ET

$65.52 USD

+0.68 (1.05%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

1-Strong Buy of 5 1        

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Mar 31, 2025

Total Return %* Percentile Rank Objective
YTD 0.98 36
3 months 0.98 36
6 months -10.27 59
1 Year -3.62 44
3 Year 4.91 6
5 Year 11.19 13
10 Year 7.36 17

* Annual for three years and beyond.

Zacks Premium Research for JNGLX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Strong Buy 1
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 33.10
% Yield 0.34
% SEC Yield NA
Net Assets (Mil $) 3/31/2025 1,650.06
% Turnover 3/31/2025 35.00

Risk

3 Year 5 Year 10 Year
Beta 0.64 0.74 0.81
Alpha -2.17 -2.47 -2.43
R Squared 0.57 0.63 0.59
Std. Dev. 14.61 15.72 16.27
Sharpe 0.11 0.61 2.00

Sector / Country Weightings

As of 3/31/2025 % of Portfolio
Health 67.57
Finance 11.37
Other 7.54
Industrial Cyclical 4.60
Technology 3.80
Services 3.32
Retail Trade 1.80

Portfolio Holdings

Top Equity Holdings
(As of 12/31/2024)
% of Portfolio Value (Mil$)
ELI LILLY & CO 8.96 427.93
UNITEDHEALTH GROUP INC 6.60 315.60
NOVO NORDISK A S B 3.65 174.61
ASTRAZENECA PLC ADR 3.65 174.46
JOHNSON & JOHNSON 3.05 145.82
BOSTON SCIENTIFIC CORP 2.83 135.03
AMGEN INC 2.80 133.66
ABBOTT LABORATORIES 2.75 131.34
SANOFI ADR 2.72 129.97

Stock Holding % of Net Assets

As Of 12/31/2024
Total Issues 90
Avg. P/E 26.34
Avg. P/Book 5.98
Avg. EPS Growth 13.03
Avg. Market Value (Mil $) 190,421

Composition

% of Portfolio
Stocks 99.41
Foreign Stocks 20.62
Cash 0.37
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.00
Convertible 0.01
Other 0.21
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth 0.00
Large Value 13.55
Small Growth 7.80
Small Value 0.00
Foreign Stock 8.00
Emerging Market 0.00
Precious Metal 2.16
Intermediate Bond 14.44
Foreign Bond 2.73
High Yield Bond 0.00